Periodontal Therapy in Coronary Artery Patients (PerioCardio)
Impact of Periodontal Therapy in Flow-mediated Dilation and Serum Levels of Cardiovascular Risk Biomarkers in Coronary Artery Disease Patients: 12 Months Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
RS
-
Porto Alegre, RS, Brazil, 90035003
- Federal University of Rio Grande do Sul, School of Dentistry and University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 35 years and older
- coronary artery disease
- more than 10 teeth
- chronic periodontitis defined as 2 non-adjacent teeth with probing depth 5+mm and periodontal attachment loss 4+mm
Exclusion Criteria:
- use of antibiotics in the last 6 months
- periodontal therapy in the last 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Comprehensive treatment
Test treatment group
|
Oral hygiene instruction and motivation will be provided altogether with scaling and root planing of all teeth affected by periodontitis under local anesthesia
|
|
Other: Community treatment
Control treatment group
|
One session of supraginigval calculus removal
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in C reactive protein
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
|
Changes in flow-mediated dilation
Time Frame: Baseline, 1, 3 and 6 months
|
Baseline, 1, 3 and 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in Interleukin 1B concentrations
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in TNF alpha
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in Interleukin 8
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in Interleukin 6
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in Cholesterol
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in Glycated hemoglobin
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in LDL/HDL
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
|
Changes in Fibrinogen
Time Frame: Baseline, 3, 6, 12 months
|
Baseline, 3, 6, 12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Alex N Haas, PhD, Federal University of Rio Grande do Sul, Periodontology
- Study Chair: Cassiano K Rosing, PhD, Federal University of Rio Grande do Sul, Periodontology
- Study Chair: Carisi Polanczyk, PhD, Federal University of Rio Grande do Sul, Cardiology
- Study Chair: Eneida RR Rabelo da Silva, PhD, Federal University of Rio Grande do Sul
- Principal Investigator: Marco A Saffi, MS, Federal University of Rio Grande do Sul, Cardiology
- Principal Investigator: Cassio Kampits, MS, Federal University of Rio Grande do Sul, Periodontology
- Principal Investigator: Ingrid Sanada, MS, Federal University of Rio Grande do Sul, Periodontology
- Principal Investigator: Marlon Montenegro, MS, Federal University of Rio Grande do Sul, Periodontology
- Study Director: Mariana V Furtado, MS, Federal University of Rio Grande do Sul, Cardiology
Publications and helpful links
General Publications
- Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008 Apr;35(4):277-90. doi: 10.1111/j.1600-051X.2007.01173.x. Epub 2008 Feb 20.
- Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, Wilson WR, Smith SC Jr, Baddour LM; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012 May 22;125(20):2520-44. doi: 10.1161/CIR.0b013e31825719f3. Epub 2012 Apr 18.
- Ramirez JH, Arce RM, Contreras A. Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial. Trials. 2011 Feb 16;12:46. doi: 10.1186/1745-6215-12-46.
- Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M. Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J. 2009 Aug;59(4):197-209.
- Montenegro MM, Ribeiro IWJ, Kampits C, Saffi MAL, Furtado MV, Polanczyk CA, Haas AN, Rosing CK. Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months. J Clin Periodontol. 2019 Mar;46(3):321-331. doi: 10.1111/jcpe.13085. Epub 2019 Mar 6.
- Saffi MA, Furtado MV, Montenegro MM, Ribeiro IW, Kampits C, Rabelo-Silva ER, Polanczyk CA, Rosing CK, Haas AN. The effect of periodontal therapy on C-reactive protein, endothelial function, lipids and proinflammatory biomarkers in patients with stable coronary artery disease: study protocol for a randomized controlled trial. Trials. 2013 Sep 6;14:283. doi: 10.1186/1745-6215-14-283.
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HCPA110146
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.